$10.30
-0.47-4.36%
At close: Jun 5, 5:00 PM EST
$10.18
-0.12-1.15%
After Hours: Jun 5, 5:53 PM EST
Keros Therapeutics Inc Earnings Estimates
KROSNASDAQ
Keros Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:KROS
Keros Therapeutics (KROS) is scheduled to report Q2 earnings on August 5, 2026. Analysts estimate EPS of $-1.23 and quarterly revenue of $635.00K.
In the most recent quarter (Q1), Keros Therapeutics reported EPS of $-1.21, missing estimates of $-0.92 by 0.32%. Revenue came in at $367.00K, missing the estimate of $2.40M by 0.85%.
Keros Therapeutics has missed EPS estimates in 2 consecutive quarters.
Over the last 4 quarters, Keros Therapeutics has averaged an EPS surprise of 0.57% and a revenue surprise of 1.39%.
Earnings Date
Aug 5
EPS Estimate
$-1.230
Quarterly Revenue Estimate
$635.00K
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$33.18M
Keros Therapeutics Earnings History
Analyze the earnings history of Keros Therapeutics using advanced sorting and filters.
Loading calendar...
Keros Therapeutics (KROS) Earnings Per Share
The chart below shows Keros Therapeutics's reported EPS compared to analyst estimates over recent quarters.
Keros Therapeutics (KROS) Revenue
The chart below shows Keros Therapeutics's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Keros Therapeutics (NASDAQ:KROS) reporting earnings?
Keros Therapeutics (KROS) is scheduled to report earnings on August 5, 2026. The last reported earnings were for reported on May 14, 2026 for Q1.
What were the latest earnings per share (EPS) for Keros Therapeutics (NASDAQ:KROS)?
The Actual EPS was $-1.21, which missed the estimate of $-0.92.
What were Keros Therapeutics’s (NASDAQ:KROS) revenues?
The Actual Revenue was $367.00K, which missed the estimate of $2.40M.
